PRPH ProPhase Labs Corp: Net earnings per share growth forecast for next year

Corporate company logo of ProPhase Labs Corp (PRPH)

The projected earnings per share for the next year on the GURU.Markets chart reflects expectation dynamics, where the 0.00 level indicates the parameter's status. The asset's stability is based on the industry's insulation from external conflicts. Transparent management at ProPhase Labs, Inc. (PRPH) ensures accountability, while ownership of powerful laboratories enables the rapid expansion of the scope of genomic research and diagnostics.

ProPhase (PRPH): Expected earnings per share trend next year from 07/04/2022 to 01/10/2026
Core merchandise of prophaselabs.com

This indicator measures the dynamics of expected earnings per share, reflecting analysts' revisions of the business's fundamental valuations for the coming year. Purchasing the asset at local highs carries a correction risk if forecasts deteriorate, making it critical to monitor the trend. The history of earnings per share expectation changes confirms the margin stability of ProPhase Labs, Inc. (PRPH), driven by long-term diagnostic contracts and high capacity utilization.

Main competitors

Net earnings per share growth forecast for next year Agilent Tech|Quest Corp (DGX) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Illumina, Inc. (ILMN)|EXAS: Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year Revvity RVTY|Expected earnings per share trend next year BIO|NNNN - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Nordion|QuidelOrtho (QDEL) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year OPK (opko.com)|CDNA (CareDx, Inc.) - Earnings growth forecast for next year|MRVI: Expected earnings per share trend next year|Earnings growth forecast for next year FLGT|Earnings growth forecast for next year Standard BioTools Corp (LAB)|Net earnings per share growth forecast for next year Cytek Biosciences, Inc. CTKB|Consensus forecast of earnings per share growth for next year orasure.com (OSUR)|Exagen Diagnostics - Earnings growth forecast for next year|Expected net earnings per share growth next year MDxHealth S.A.|LUCD (Lucid Diagnostics Inc) - Expected earnings per share growth for next year|Prenetics - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Insight Molecular Diagnostics, Inc.|Net earnings per share growth forecast for next year TRIB|Earnings growth forecast for next year AIMD|Earnings growth forecast for next year Co-Diagnostics Inc (CODX)|Earnings growth forecast for next year HSCS (Heart Test Laboratories Inc.)|Biomerica Inc - Net earnings per share growth forecast for next year|CDIO - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year onconetix.gcs-web.com ONCO|VRAX (Virax Biolabs) - Expected earnings per share growth for next year|Bluejay Diagnostics Inc - Expected earnings per share trend next year|AWH (Vermillion) - Earnings growth forecast for next year|Accelerate Diagnostics Inc (AXDX) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Centogene NV (CNTG)|enzo.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year FRES (Fresh2 Group)|GENE - Expected earnings per share growth for next year|ME: Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year Psychemedics Inc PMD